Ryan Ho Yan Wong is Chief Financial Officer of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 136,045 shares of SRPT, which is worth approximately $2.56 Million. The most recent transaction as insider was on Dec 01, 2025, when has been sold 158 shares (Common Stock) at a price of $20.96 per share, resulting in proceeds of $3,311. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 136K
0.12% 3M change
n/a 12M change
Total Value Held $2.56 Million

Ryan Ho-Yan Wong Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 01 2025
SELL
Payment of exercise price or tax liability
$3,311 $20.96 p/Share
158 Reduced 0.12%
136,045 Common Stock
Sep 03 2025
BUY
Grant, award, or other acquisition
-
118,875 Added 46.6%
136,203 Common Stock
Jul 31 2025
SELL
Payment of exercise price or tax liability
$5,369 $16.42 p/Share
327 Reduced 1.85%
17,328 Common Stock
RHW

Ryan Ho Yan Wong

Chief Financial Officer
Cambridge, MA

Track Institutional and Insider Activities on SRPT

Follow Sarepta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

News

Receive news related to Sarepta Therapeutics, Inc.

Track Activities on SRPT